Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 501–600 of 942
Constitutive overexpression of periostin delays wound healing in mouse skin
Nunomura, S., Nanri, Y., Ogawa, M., Arima, K., Mitamura, Y., Yoshihara, T., Hasuwa, H., Conway, S. J., & Izuhara, K. (2018) · Wound Repair and Regeneration · doi:10.1111/wrr.12616 · Cited by 21
“M1-like macrophages and neutrophils are the principal sources of IL-1b and TNFa during wound repair.22–24 It was recently reported that treating mouse intraperitoneal macrophages with high doses of recombinant periostin changes the characteristics of these macrophages, decreasing expression of M1 markers including IL-…”
BackgroundPeriostin Links Skin Inflammation to Melanoma Progression in Humans and Mice
Ohno, F., Nakahara, T., Kido‐Nakahara, M., Ito, T., Nunomura, S., Izuhara, K., & Furue, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010169 · Cited by 22
“Intriguingly, periostin facilitates the recruitment of CD163+ M2 macrophages, which potently induces immune tolerance and promotes tumor progression [23].”
BackgroundLuo, M., Liu, Y., Zhang, H., Luo, C., Liu, Q., Wang, W., He, Z.-C., Chen, C., Zhang, X., Mao, M., et al. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00724-0 · Cited by 20
Zhang, Y., Zhu, S., Yuan, Z., Li, Q., Ding, R., Bao, X., Zhen, T., Fu, Z., Fu, H., Xing, K., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07626-2 · Cited by 23
Liu, X., Huang, Y., Qi, Y., Wu, S., Hu, F., Wang, J., Shu, K., Zhang, H., Bartsch, J. W., Nimsky, C., et al. (2022) · Cancers · doi:10.3390/cancers14194910 · Cited by 21
“also found that TAMs recruited by glioblastoma stem cells promoted malignant growth [14].”
BackgroundFeyissa, A. M., Rosenfeld, S. S., & Quiñones‐Hinojosa, A. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120488 · Cited by 24
Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment
Sípos, F., & Műzes, G. (2023) · Biomedicines · doi:10.3390/biomedicines11010189 · Cited by 24
Sidorov, M. K., Dighe, P. A., Woo, R. W. L., Rodriguez-Brotons, A., Chen, M. M., Ice, R. J., Vaquero, E. M., Jian, D., Desprez, P., Nosrati, M., et al. (2023) · Cells · doi:10.3390/cells12040547 · Cited by 21
“We used a “surrogate” human macrophage cell line (U937; [41]), primed toward an M2 phenotype, and performed transwell migration assays using chemoattractants supernatants from GBM192 and GBM218 treated with erlotinib, MLN0128, or the combination of the two drugs.”
BackgroundMethodDeep dissection of stemness-related hierarchies in hepatocellular carcinoma
Liang, R., Hong, W., Zhang, Y., Ma, D., Li, J., Shi, Y., Luo, Q., Du, S., & Guanbin, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04425-8 · Cited by 22
“CSCs can secrete immunosuppressive cytokines that enable tumor-associated macrophages to secrete multiple inflammatory cytokines and recruit myeloid-derived suppressor cells (MDSCs), thereby facilitating the formation of a tumor microenvironment conducive to CSCs’ survival [51, 52].”
BackgroundNanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
Ghosh, A. K., Ghosh, A., & Das, P. K. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04714 · Cited by 22
Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
Nayak, A., Warrier, N. M., Raman, R., Prabhu, V., & Kumar, P. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105980 · Cited by 24
Hu, Y., Yi, Z., Zhou, Y., Li, P., Liu, Z., Duan, S., & Gong, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5551 · Cited by 20
“Tumor-associated macrophages (TAMs) and their alternative activation contribute greatly to the development of HCC (8-10).”
BackgroundIrradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas
Nesseler, J. P., Schaue, D., McBride, W. H., Lee, M.-H., Kaprealian, T. B., Niclou, S. P., & Nickers, P. (2018) · Advances in Radiation Oncology · doi:10.1016/j.adro.2018.11.005 · Cited by 21
Lin, J., & Lin, N. (2020) · Genomics · doi:10.1016/j.ygeno.2020.10.008 · Cited by 22
Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease
Prakoura, N., & Chatziantoniou, C. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00052 · Cited by 22
Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
Moyes, K. W., Davis, A. D., Hoglund, V. J., Haberthur, K., Lieberman, N. A. P., Kreuser, S. A., Deutsch, G. H., Franco, S., Locke, D., Carleton, M. O., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1507668 · Cited by 23
Zhang, H., Shan, G., Song, J., Tian, Y., An, L., Ban, Y., & Luo, G. (2020) · Bioscience Reports · doi:10.1042/bsr20194192 · Cited by 19
Al‐Holou, W. N., Wang, H., Ravikumar, V., Shankar, S., Oneka, M. D., Fehmi, Z., Verhaak, R. G. W., Kim, H., Pratt, D. W., Camelo-Piragua, S. I., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2022.100872 · Cited by 21
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
Liu, J., Piranlioglu, R., Ye, F., Shu, K., Lei, T., & Nakashima, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1141034 · Cited by 27
“, 2011), results in the secretion of cytokines and chemokines such as MIC-1, periostin, IL-33, andMCP-1 (Wu et al., 2010; Zhou et al., 2015; Roesch et al., 2018; De Boeck et al., 2020), which recruit blood-borne monocytes and macrophages to the tumor site, polarizing them into M2 TAMs.”
BackgroundLvu, W., Xu, F., Chen, C., & Zhang, B. (2020) · Bioscience Reports · doi:10.1042/bsr20201037 · Cited by 20
“Along with ABCC3, POSTN (periostin) was also identified to be the important regulator in the tumorigenesis and treatment of glioma [36,37].”
Glioma Pericytes Promote Angiogenesis by Producing Periostin
Bernardes, S. S., Pinto, M. C. X., Amorim, J. H., Azevedo, V., Resende, R. R., Mintz, A., & Birbrair, A. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00975-3 · Cited by 23
Microenvironmental Drivers of Glioma Progression
Jang, H. J., & Park, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052108 · Cited by 28
Rotoli, D., Pérez-Rodríguez, N. D., Morales, M., Maeso, M. D. C., Ávila, J., Mobasheri, A., & Martín-Vasallo, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010150 · Cited by 18
Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status
Zhou, F., Shi, Q., Fan, X., Yu, R., Wu, Z., Wang, B., Tian, W., Yu, T., Pan, M., You, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841404 · Cited by 20
Pathophysiological roles of integrins in gliomas from the perspective of glioma stem cells
Wang, M., Shen, S., Hou, F., & Yan, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.962481 · Cited by 22
“may be a potential target for the design of effective immunotherapies to improve the survival of GBM patients (Shi et al., 2015; Zhou et al., 2015).”
BackgroundInfluentialChulpanova, D. S., Rizvanov, A. A., & Solovyeva, V. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010395 · Cited by 18
Zhou, X., Jin, G., Zhang, J., & Liu, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1067641 · Cited by 21
“Studies have shown that some cytokines are more likely to recruit macrophages derived from monocytes in peripheral blood (31).”
BackgroundFan, H., Li, L., Zhang, Y.-M., Yang, J., Li, M.-C., Zeng, F., & Deng, F. (2017) · Tumor Biology · doi:10.1177/1010428317701442 · Cited by 18
Research status and the prospect of POSTN in various tumors
Yu, Y., Tan, C., & Jia, Y. (2021) · Neoplasma · doi:10.4149/neo_2021_210223n239 · Cited by 20
Research Progress About Glioma Stem Cells in the Immune Microenvironment of Glioma
Li, X., Liu, M., Zhao, J., Ren, T., Yan, X., Zhang, L., & Wang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.750857 · Cited by 20
“Microglia can also promote stem cell differentiation by releasing IL-6 (Wang et al., 2009; Zhang et al., 2012), which in turn induces GSCs to recruit anti-inflammatory macrophages by releasing osteoperioprotein (Zhou et al., 2015).”
BackgroundDalpati, N., Rai, S. K., Sharma, P., & Sarangi, P. P. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.12.003 · Cited by 21
Noyori, O., Komohara, Y., Nasser, H., Hiyoshi, M., Ma, C., Pan, C., Carreras, J., Nakamura, N., Sato, A., Ando, K., et al. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1074 · Cited by 18
“Because of these discrepancies,(36) we simply assessed the total number of macrophages, that is macrophages positive for Iba-1 (also known as AIF-1), because Iba-1 originally used as a marker for microglia is recently recognised as a pan-macrophage marker.(12,37,38) Indeed, we found that the number of Iba-1 macrophage…”
BackgroundXu, X., Ma, J., Yu, G., Qiu, Q., Zhang, W., & Cao, F. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155421991938 · Cited by 21
Fujikawa, T., Sanada, F., Taniyama, Y., Shibata, K., Katsuragi, N., Koibuchi, N., Akazawa, K., Kanemoto, Y., Kuroyanagi, H., Shimazu, K., et al. (2021) · Cancers · doi:10.3390/cancers13205072 · Cited by 18
“Pn is known to be the factor that recruits and polarizes TAMs, causing chemoresistance in pancreatic cancer and glioblastoma [28,32].”
BackgroundLi, J., Yang, J., Xing, R., & Wang, Y. (2023) · Aging · doi:10.18632/aging.204630 · Cited by 19
Martins, C., & Sarmento, B. F. C. C. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1893 · Cited by 20
Nabbi, A., Beck, P., Delaidelli, A., Oldridge, D. A., Sudhaman, S., Zhu, K., Yang, S. Y. C., Mulder, D. T., Bruce, J. P., Paulson, J. N., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01219-x · Cited by 16
“6G), the latter of which recruit tumour-associated macrophages (TAM) in adult glioblastoma [111, 112].”
BackgroundIntegrins as Key Mediators of Metastasis
Cáceres-Calle, D., Torre-Cea, I., Marcos-Zazo, L., Carrera-Aguado, I., Guerra-Paes, E., Berlana-Galán, P., Muñoz‐Félix, J. M., & Sánchez‐Juanes, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030904 · Cited by 22
Rodent Models to Analyze the Glioma Microenvironment
Hetze, S., Sure, U., Schedlowski, M., Hadamitzky, M., & Barthel, L. (2021) · ASN NEURO · doi:10.1177/17590914211005074 · Cited by 19
Liang, W., Wang, Y., Zhang, Q., Gao, M., Zhou, H., & Wang, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.781867 · Cited by 17
Tabu, K., Liu, W., Kosaku, A., Terashima, K., Murota, Y., Aimaitijiang, A., Nobuhisa, I., Hide, T., & Taga, T. (2020) · Stem Cells · doi:10.1002/stem.3193 · Cited by 17
“It is noteworthy that a Th2 cytokine periostin (POSTN) was identified as a GSC-derived factor to recruit tumor-associated Mφs (TAMs).(45)”
BackgroundShan, X., Zhang, C., Wang, Z., Wang, K., Wang, J., Qiu, X., Jiang, T., & Yang, P. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108430 · Cited by 19
Ispirjan, M., Marx, S., Freund, E., Fleck, S. K., Baldauf, J., Rössler, K., Schroeder, H. W. S., & Bekeschus, S. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2425124 · Cited by 19
Zhang, Y., He, H., Fu, X., Liu, G., Wang, H., Zhong, W., Xu, X., Chen, B., & Mei, L. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00905-9 · Cited by 23
“GBM stem cells (GSCs) are GBM-initiating cells that also attract M2 tumor-associated macrophages and promote malignant expansion by releasing periostin [77].”
Wan, S., Moure, U. A. E., Liu, R., Liu, C., Wang, K., Deng, L., Liang, P., & Cui, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013094 · Cited by 17
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
Zhang, Y., Zhao, L., Bi, Y., Zhao, J., Gao, C., Si, X., Dai, H., Asmamaw, M. D., Zhang, Q., Chen, W., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115207 · Cited by 18
Biomedical engineering targeting cancer stem cells to reinforce cancer therapy
Sun, S., Yang, N., Pei, Z., Gong, F., & Cheng, L. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216494 · Cited by 18
Rajayi, H., Tavasolian, P., Rezalotfi, A., & Ebrahimi, M. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1669593 · Cited by 16
“On the other hand, CSCs educate the fibroblasts or any other stromal cells or even CSCs themselves in the target site to produce POSTN.”
BackgroundInfluentialFeng, Y., Chen, Q., Lau, S., Tsai, B. W., Groom, K. M., Barrett, C. J., & Chamley, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113115 · Cited by 18
A niche role for periostin and macrophages in glioblastoma
Squadrito, M. L., & Palma, M. D. (2015) · Nature Cell Biology · doi:10.1038/ncb3095 · Cited by 16
Ellert‐Miklaszewska, A., Pilanc, P., Poleszak, K., Roura, A.-J., Cyranowski, S., Ghosh, M., Baluszek, S., Pasierbińska, M., Gielniewski, B., Swatler, J., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03393-9 · Cited by 23
“Preclinical data from rodent glioma models, including ours, highlight the importance of αvβ3/αvβ5 integrin signaling in recruitment [23] and phenotype decision-making in GAMs [21, 22].”
Sang, S., Sun, Z., Zheng, W., Wang, W., Islam, M. T., Chen, Y., Yuan, Q., Cheng, C., Xi, S., Han, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102242 · Cited by 19
Harnessing innate immunity against glioblastoma microenvironment
Zhang, W., Zhang, W., Wu, H., & Han, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648601 · Cited by 24
Correnti, M., Binatti, E., Gammella, E., Invernizzi, P., & Recalcati, S. (2022) · Cancers · doi:10.3390/cancers15010005 · Cited by 15
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
Rafii, S., Kandoussi, S., Ghouzlani, A., Naji, O., Reddy, K. P., Sadiqi, R. U., & Badou, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135430 · Cited by 16
“Furthermore, when disrupting POSTN in the in vivo model, it significantly reduced the recruitment of the TAMs, especially those of the M2 phenotype and inhibited GBM tumor growth (20).”
BackgroundPan, T., Xie, D.-K., Li, J., Qiang, Y.-J., Fan, S.-Y., Wang, T., Han, Y., Zang, J., Yang, Y., Zhao, J., et al. (2024) · Cancers · doi:10.3390/cancers16142500 · Cited by 16
“Zhou et al. demonstrated an involvement of GSCs in the modification of the immunosuppressive microenvironment by secreting periostin (POSTN) to recruit M2-type TAMs and promote GBM progression and tumor recurrence [45].”
BackgroundZhou, F., Tao, J., Gou, H., Liu, S., Dong, Y., Zhang, J., Ji, J., Lin, N., & Wang, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217400 · Cited by 20
Deficiency of periostin impairs liver regeneration in mice after partial hepatectomy
Wu, T., Huang, J., Wu, S., Huang, Z., Chen, X., Liu, Y., Cui, D., Song, G., Luo, Q., Liu, F., et al. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.09.004 · Cited by 16
Wu, Y., Song, Z., Sun, K., Rong, S., Gao, P., Wang, F., & Sun, T. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s236598 · Cited by 15
Pre-surgery immune profiles of adult glioma patients
Bracci, P. M., Rice, T., Hansen, H. M., Francis, S. S., Lee, S., Mccoy, L. S., Shrestha, P., Warrier, G., Clarke, J. L., Molinaro, A. M., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04047-y · Cited by 17
“If possible, immune measures taken before dexamethasone use begins could be very helpful to disentangle the effects of dexamethasone from tumor related immune suppression and to clarify the complex association between tumor immune infiltrates, such as monocyte-derived M2 tumor-associated macrophages that promote GBM t…”
BackgroundCancer Stem Cell-Associated Immune Microenvironment in Recurrent Glioblastomas
Murota, Y., Tabu, K., & Taga, T. (2022) · Cells · doi:10.3390/cells11132054 · Cited by 16
Can 3D bioprinting solve the mystery of senescence in cancer therapy?
Shboul, S. A., DeLuca, V. J., Dweiri, Y. M., & Saleh, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101732 · Cited by 17
Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
Chen, H., Nikolić, A., Singhal, D., & Gallo, M. (2022) · Cancers · doi:10.3390/cancers14194942 · Cited by 20
“This is partly due to migration of peripheral macrophages to tumours driven by secreted factors such as periostin (POSTN) [91].”
BackgroundLi, Y., Wang, W., Hou, X., Huang, W., Zhang, P., He, Y., Wang, B., Duan, Q., Mao, F., & Guo, D. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05555-z · Cited by 15
“It has been reported that the density and M1–M2 polarity transformation of TAMs are related to the prognosis of glioma patients [11].”
BackgroundLi, W., Zhao, B., Wang, Q., Lu, J., Wu, X., & Chen, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112807 · Cited by 15
Gravina, G. L., Mancini, A., Mattei, C. D., Vitale, F., Marampon, F., Colapietro, A., Rossi, G., Ventura, L., Vetuschi, A., Cesare, E. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16168 · Cited by 14
“Macrophages, specifically tumor-associated macrophages (TAMs), are the most common cell type among tumor-infiltrating immune cells [8, 9].”
BackgroundZhu, M., Jiang, L., Yuan, Y., Chen, L., Liu, X., Liang, J., Zhu, Q., Ding, D., & Song, E. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03001-1 · Cited by 15
Tang, Y., Chen, Y., Huang, L., Gao, F., Sun, H., & Huang, C. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00233 · Cited by 14
Baker, G. J., Muhlich, J. L., Palaniappan, S. K., Moore, J. K., Davis, S. H., Santagata, S., & Sorger, P. K. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.001 · Cited by 13
“…immune cells by producing anti-inflammatory cytokines and catabolites (Maxwell et al., 1992; Huettner et al., 1997; Crane et al., 2014; Wainwright et al., 2012; Zhou et al., 2015), lectins (Baker et al., 2014, 2016), and immune checkpoint molecules (Wainwright et al., 2014; Bloch et al., 2013).”
Long-lived tumor-associated macrophages in glioma
Georgieva, P. B., Mathivet, T., Alt, S., Giese, W., Riva, M., Balcer, M., & Gerhardt, H. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa127 · Cited by 17
Tian, R., Li, Y., Liu, Q., & Shu, M. (2021) · Cancers · doi:10.3390/cancers13071730 · Cited by 21
“Although macrophages should be able to kill tumor cells, immunosuppressive microenvironment most often polarizes TAMs into tumor-supporting cells (M2-like macrophages) rather than pro-inflammatory subtypes (M1-like macrophages), which promote immunosuppression, angiogenesis, and extracellular matrix [46,47].”
BackgroundFive-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells
Beals, N., Thiagarajan, P. S., Soehnlen, E. S., Das, A., Reizes, O., Lathia, J. D., & Basu, S. (2017) · ACS Omega · doi:10.1021/acsomega.7b01168 · Cited by 13
Zhang, T., Li, J., Dai, J., Yuan, F., Yuan, G., Chen, H., Zhu, D., Mao, X., Qin, L., Liu, N., et al. (2023) · Cancer Genetics · doi:10.1016/j.cancergen.2023.07.005 · Cited by 13
Wang, C., Xu, Y., Xu, H., Li, K., Zhang, Q., Shi, L., Zhao, L., & Chen, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02240-3 · Cited by 19
Macrophages as Targets in Hepatocellular Carcinoma Therapy
Liu, Y., Mao, Z., Ding, Y., & Wang, W. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0660 · Cited by 17
Periostin: a potent chemotactic factor for recruiting tumor-associated macrophage
Wu, T., Luo, Q., & Ouyang, G. (2015) · Protein & Cell · doi:10.1007/s13238-015-0141-9 · Cited by 14
“Using in vitro migration and invasion assays, Zhou et al. (2015) identified periostin (POSTN) as one of the most abundant GSC-secreted cytokines to potently attract macrophages.”
BackgroundInfluentialImmunological and clinicopathological characteristics of C1RL in 2120 glioma patients
Wang, J., Tong, L., Lin, G., Wang, H., Zhang, L., & Yang, X. (2020) · BMC Cancer · doi:10.1186/s12885-020-07436-6 · Cited by 13
The Vasculature in Pulmonary Fibrosis
Engelbrecht, E., Kooistra, T., & Knipe, R. S. (2022) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-022-00040-9 · Cited by 14
Xu, H., Chen, X., Yu, Z.-L., & Xue, F. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115855 · Cited by 14
Nizar, R., Cazacu, S., Xiang, C., Krasner, M., Barbiro‐Michaely, E., Gerber, D., Schwartz, J., Fried, I., Bar‐Asher, S. Y., Brodie, A., et al. (2023) · Cells · doi:10.3390/cells12151921 · Cited by 21
“These cells have been reported to undergo differentiation to an anti-inflammatory/protumorigenic state in response to factors secreted by tumor cells, which further supports tumor growth [11].”
BackgroundIdentification of Motile Sperm Domain–Containing Protein 2 as Regulator of Human Monocyte Migration
Mendel, I., Yacov, N., Salem, Y., Propheta‐Meiran, O., Ishai, E., & Breitbart, E. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601662 · Cited by 13
“Secretion of periostin by glioblastoma cells recruited tumor-associated macrophages that enhanced tumor growth (10), whereas removal of circulating and intratumor macrophages in melanomabearing mice inhibited tumor growth (11).”
BackgroundBryukhovetskiy, I., Ponomarenko, A. I., Lyakhova, I., Zaitsev, S., Zayats, Y., Korneyko, M., Елисейкина, М. Г., Mischenko, P., Шевченко, В. Е., Sharma, H. S., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3668 · Cited by 13
“Production of periostin (131) and other EMT moderators is mainly attributed to cells expressing M2 microglial markers in the cSc microenvironment.”
Periostin: Immunomodulatory Effects on Oral Diseases
Khurshid, Z., Mali, M., Adanir, N., Zafar, M. S., Khan, R. S., & Latif, M. (2020) · European Journal of Dentistry · doi:10.1055/s-0040-1714037 · Cited by 14
“29 In another study conducted by Wang et al, they demonstrated the limitations that periostin brings in metastatic colonization in disseminated breast tumor cells.”
BackgroundHatlen, R. R., & Rajagopalan, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.044 · Cited by 14
Tumor‐associated macrophages as treatment targets in glioma
Peng, Y., Chen, F., Li, S., Liu, X., Wang, C., Yu, C., & Li, W. (2020) · Brain Science Advances · doi:10.26599/bsa.2020.9050015 · Cited by 13
“Decreased TAMs prolongs the survival of mice with GSC‐derived xenografts [94].”
BackgroundChen, Z., Liu, L., Chen, Y., Liu, M., Xiang, A. P., Deng, C., & Jiang, M. H. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac025 · Cited by 13
Fujimura, T., Kakizaki, A., Sato, Y., Tanita, K., Furudate, S., & Aiba, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11639 · Cited by 13
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation
Clemente-González, C., & Carnero, A. (2022) · Cancers · doi:10.3390/cancers14235930 · Cited by 14
“Periostin is a protein that binds collagen and fibronectin and activates the AKT and STAT3 signaling pathways, thereby recruiting myeloid suppressor cells and creating an immunosuppressive environment in the secondary organ [69].”
BackgroundLi, D., Wang, L., Jiang, B., Jing, Y., & Li, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116043 · Cited by 13
Fu, Z., Chen, Z., Ye, J., Ji, J., Ni, W., Lin, W., Lin, H., Lu, L., Zhu, G., Xie, Q., et al. (2024) · Cancers · doi:10.3390/cancers16040840 · Cited by 13
“MES-phenotype GBM typically shows more abundant immune component infiltration than other subtypes, which is related to its higher secretion of chemokines such as POSTN [24].”
BackgroundDey, T., Ghosh, A., Sanyal, A., Charles, C. J., Pokharel, S., Nair, L. S., Singh, M., Kaity, S., Ravichandiran, V., Kaur, K., et al. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad3abb · Cited by 12
Pathophysiological role of histamine signaling and its implications in glioblastoma
Yadav, P., Vengoji, R., Jain, M., Batra, S. K., & Shonka, N. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189146 · Cited by 15
Metabolic adaptation of myeloid cells in the glioblastoma microenvironment
Essakhi, N., Bertucci, A., Baeza, N., Colin, C., Lavignolle, R., García-González, P. A., Argüello, R. J., Tchoghandjian, A., & Tabouret, É. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431112 · Cited by 14
Molecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas
Liu, X., Li, Y., Sun, Z., Li, S., Wang, K., Fan, X., Liu, Y., Wang, L., Wang, Y., & Jiang, T. (2018) · Cancer Medicine · doi:10.1002/cam4.1672 · Cited by 13
Highlights from the Literature
Wick, W., Soffietti, R., Aldape, K., Mansouri, S., Huse, J. T., & Aldape, K. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov056 · Cited by 12
Prognostic Value and Biological Function of Galectins in Malignant Glioma
Zhu, H., Liu, D., Cheng, L., Liu, J., Wang, G., Li, H., Zhang, Y., Mi, H., Zhang, S., Shu, K., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834307 · Cited by 14
Perspective on Translating Biomaterials Into Glioma Therapy: Lessons From in Vitro Models
Cornelison, R. C., & Munson, J. M. (2018) · Frontiers in Materials · doi:10.3389/fmats.2018.00027 · Cited by 14
“Glioma-derived ECM molecules also alter immune cell phenotype, with periostin acting to recruit and train monocytes toward pro-tumor phenotypes and tenascin-c protecting tumor cells from immune surveillance by arresting T-cell activation (Jachetti et al., 2015; Zhou et al., 2015).”
BackgroundCifola, I., Fratini, F., Cardinali, B., Palmieri, V., Gatti, G., Selmi, T., Donzelli, S., Sacconi, A., Cesarini, V., Marei, H. E. S., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10081886 · Cited by 12
“In addition, CSCs can evade the immune system, promoting M2 polarization of resident macrophages and inhibiting T cell response [60,61].”
BackgroundTargeting FGL2 in glioma immunosuppression and malignant progression
Ma, X., Zhu, H., Cheng, L., Chen, X., Shu, K., & Zhang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1004700 · Cited by 11
“TAMs and glioma cells are important components in promoting glioma growth, and their interactions are critical for glioma proliferation, treatment resistance, and tumor recurrence (98).”
BackgroundWu, S., Li, X., Hong, F., Chen, Q., Yu, Y., Guo, S., Xie, Y., Xiao, N., Kong, X., Mo, W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1028775 · Cited by 14
“MDMs promote tumor growth by secreting growth factors (37).”
Background
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.